Structures by: Saraiva Costa W. E.
Total: 13
Benzoylmetronidazole--fumaric acid (2/1)
2(C13H13N3O4),C4H4O4
Acta Crystallographica Section C (2019) 75, 5
a=9.0358(5)Å b=26.6419(14)Å c=6.8796(3)Å
α=90° β=102.419(2)° γ=90°
Benzoylmetronidazole—–β-naphthol (1/1)
C13H13N3O4,C10H8O
Acta Crystallographica Section C (2019) 75, 5
a=8.5105(8)Å b=22.387(2)Å c=11.7752(11)Å
α=90° β=108.664(4)° γ=90°
Benzoylmetronidazole--benzoic acid (1/1)
C13H13N3O4,C7H6O2
Acta Crystallographica Section C (2019) 75, 5
a=13.5997(6)Å b=9.0354(4)Å c=16.5974(8)Å
α=90° β=108.646(2)° γ=90°
Benzoylmetronidazole--4-methoxybenzoic acid (1/1)
C13H13N3O4,C8H8O3
Acta Crystallographica Section C (2019) 75, 5
a=9.1309(4)Å b=11.1274(4)Å c=11.8538(5)Å
α=107.3650(10)° β=103.2700(10)° γ=110.0910(10)°
Benzoylmetronidazole--3,5-dinitrobenzoic acid (1/1)
C13H13N3O4,C7H4N2O6
Acta Crystallographica Section C (2019) 75, 5
a=21.0988(13)Å b=8.4322(5)Å c=12.0341(8)Å
α=90° β=99.505(2)° γ=90°
Benzoylmetronidazole--maleic acid (1/1)
C13H14N3O4,C4H3O4
Acta Crystallographica Section C (2019) 75, 5
a=43.130(3)Å b=5.7944(4)Å c=15.2645(11)Å
α=90° β=109.600(3)° γ=90°
Benzoylmetronidazole--3-aminobenzoic acid (1/1)
C13H13N3O4,C7H7NO2
Acta Crystallographica Section C (2019) 75, 5
a=7.9316(7)Å b=11.9585(12)Å c=12.1978(12)Å
α=76.362(3)° β=78.927(3)° γ=79.583(3)°
Benzoylmetronidazole--salicylic acid (1/1)
C13H13N3O4,C7H6O3
Acta Crystallographica Section C (2019) 75, 5
a=9.5055(6)Å b=31.2239(19)Å c=6.8578(4)Å
α=90° β=102.628(2)° γ=90°
Benzoylmetronidazole--isophthalic acid (1/1)
C13H13N3O4,C8H6O4
Acta Crystallographica Section C (2019) 75, 5
a=8.8300(3)Å b=33.7182(10)Å c=7.3199(2)Å
α=90° β=107.8780(10)° γ=90°
Benzoylmetronidazole--2,6-dihydroxybenzoic acid (1/1)
C13H14N3O4,C7H5O4
Acta Crystallographica Section C (2019) 75, 5
a=8.2443(4)Å b=15.9009(7)Å c=15.4526(8)Å
α=90° β=102.454(2)° γ=90°
Benzoylmetronidazole--malonic acid (4/1)
2(C13H13N3O4),0.5(C6H4O8)
Acta Crystallographica Section C (2019) 75, 5
a=26.1542(4)Å b=7.27080(10)Å c=16.6719(3)Å
α=90° β=90° γ=90°
Benzoylmetronidazole--3,5-dihydroxybenzoic acid (3/1)
3(C13H13N3O4),C7H6O4
Acta Crystallographica Section C (2019) 75, 5
a=7.1481(2)Å b=36.7892(8)Å c=18.0584(4)Å
α=90° β=100.4510(10)° γ=90°
Benzoylmetronidazole--resorcinol (2/1)
2(C13H13N3O4),C6H6O2
Acta Crystallographica Section C (2019) 75, 5
a=26.3241(4)Å b=7.16120(10)Å c=33.8433(5)Å
α=90° β=90° γ=90°